Dr. Ramesh V. Nathan, MD

Dr. Nathan practices at Thousand Oaks Surgical Institute, A.M.C in Thousand Oaks, California.

Dr. Nathan's NPI, 1215025291, was assigned on October 11, 2006. Dr. Nathan graduated from George Washington University School of Medicine and Health Sciences in 2000. Dr. Nathan's California license number on file is A77898.

Dr. Nathan's primary practice is Thousand Oaks Surgical Institute, A.M.C, at 375 E Rolling Oaks Dr, Thousand Oaks, CA 91361 in Ventura County. The practice phone is (805) 777-8956.

Dr. Nathan's primary practice is Thousand Oaks Surgical Institute, A.M.C in Thousand Oaks, California. Dr. Nathan is also affiliated with Los Robles Regional Medical Center. The medical group on file is Mazur Statner And Dutta Medical Group. Dmand AI also links Dr. Nathan to 2 more hospitals, 3 home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nathan practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Nathan's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Nathan is board certified in infectious disease by the American Board of Internal Medicine. Dr. Nathan has a license on file in California.

Dmand AI lists acute skin infection, facial skin infection, immune deficiency disease, joint or bone infection, pneumonia, shingles and UTI among the conditions Dr. Nathan treats.

CMS data shows 49,771 Medicare services from Dr. Nathan across 17 procedure codes in 2024, for 691 Medicare patients. Medicare paid $264,980 for them.

CMS counts 691 Medicare patients who saw Dr. Nathan in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nathan's median patient age at 70, with 47% women.

In 2024, Dr. Nathan wrote 1,908 Medicare Part D claims for 214 patients. 87% of them were for generic drugs. CMS names the drug for 1,588 of them, across 68 drugs with 11 or more claims each, at $145,693 in total drug cost. In 2023, CMS named 1,662 claims across 67 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Nathan for performance year 2024, reported individually. Dr. Nathan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nathan as offering telehealth.

Dmand AI links 11 papers to Dr. Nathan, published from 2020 to 2022. 2020 was the busiest year, with 3. Dr. Nathan's most frequent co-authors are Richard Lowell Hengel, MD, Timothy E. Ritter, MD and John Richard Dingilian, MD.

Dmand AI links Dr. Nathan to 5 clinical trials. 1 is still active or recruiting. Conditions studied include COVID-19, Pneumonia, Viral and Alzheimer Disease. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Nathan that name 3 trials.

CMS Open Payments shows 241 general payments to Dr. Nathan from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $26,338. It also lists 5 research payments totaling $270,675 from 2020 to 2022, naming 3 clinical trials.

Dmand AI lists 13 awards for Dr. Nathan, most recently Faculty Teaching Award in 2023. Dr. Nathan serves on Antimicrobial Management Program.

Dr. Nathan graduated from George Washington University School of Medicine and Health Sciences in 2000. Dr. Nathan is a member of IDSA.

Dr. Nathan is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.